The Expression and Significance of MiRNA
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Pulmonary Arterial Hypertension
Related studies linked through entity extraction aliases.
Study Looking at Combination Therapy (Sitaxsentan+Sildenafil) Vs. Monotherapy (Sitaxsentan Alone) SR-PAAS -Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil
- Status
- TERMINATED
- Phase
- PHASE3
Study Providing Monotherapy (Sitaxsentan) And Combination Therapy (Sitaxsentan+Sildenafil) To Subjects With Pulmonary Arterial Hypertension (PAH) To Assess Long-Term Safety
- Status
- TERMINATED
- Phase
- PHASE3
Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS)
- Status
- TERMINATED
- Phase
- PHASE3
An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Multi-Center, Open-Label, Multiple Dose, Dose Finding Study Exploring the Safety and Tolerability of Beraprost Sodium Modified Release in PAH Patients
- Status
- COMPLETED
- Phase
- PHASE2
Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension (PAH) Subjects
- Status
- COMPLETED
- Phase
- PHASE4
Iloprost Power Disc-15 in Pulmonary Arterial Hypertension
- Status
- TERMINATED
- Phase
- PHASE3
Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder
- Status
- TERMINATED
- Phase
- N/A
Iloprost Power 15 in Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc)
- Status
- TERMINATED
- Phase
- N/A
Long Acting Phosphodiesterase 5 Inhibitors as Add-on Therapy for Patients With Pulmonary Hypertension Treated With Prostanoids.
- Status
- UNKNOWN
- Phase
- PHASE4
Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan
- Status
- WITHDRAWN
- Phase
- PHASE4
Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil
- Status
- WITHDRAWN
- Phase
- PHASE4
Correlation OF Hemodynamics in Pulmonary Hypertension With Perfusion Lung Scans
- Status
- COMPLETED
- Phase
- N/A
Pulmonary Arterial Hypertension in Systemic Sclerosis
- Status
- UNKNOWN
- Phase
- N/A